PubMed

Perceptions of heart attack risk amongst individuals with diabetes.

Price HC, Dudley C, Barrow B, Griffin SJ, Holman RR.

Prim Care Diabetes. 2009 Nov 4. [Epub ahead of print]PMID: 19896425 [PubMed - as supplied by publisher]Related articles

Presenting the results of clinical trials to participants.

Darbyshire JL, Holman RR, Price HC.

Clin Med. 2009 Oct;9(5):415-6. No abstract available. PMID: 19886097 [PubMed - in process]Related articles

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes.

Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE; the A Diabetes Outcome Progression Trial Study Group.

J Clin Endocrinol Metab. 2009 Oct 29. [Epub ahead of print]PMID: 19875477 [PubMed - as supplied by publisher]Related articles

Three-year efficacy of complex insulin regimens in type 2 diabetes.

Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK; 4-T Study Group.

N Engl J Med. 2009 Oct 29;361(18):1736-47. Epub 2009 Oct 22.PMID: 19850703 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial).

Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B; for the ADOPT Study Group.

Diabetes Care. 2009 Oct 16. [Epub ahead of print]PMID: 19808911 [PubMed - as supplied by publisher]Related articles

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M.

Diabetologia. 2009 Nov;52(11):2288-98. Epub 2009 Aug 5.PMID: 19655124 [PubMed - in process]Related articles

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses.

Lasserson DS, Glasziou P, Perera R, Holman RR, Farmer AJ.

Diabetologia. 2009 Oct;52(10):1990-2000. Epub 2009 Jul 31.PMID: 19644668 [PubMed - in process]Related articles

Use of focus groups to develop methods to communicate cardiovascular disease risk and potential for risk reduction to people with type 2 diabetes.

Price HC, Dudley C, Barrow B, Kennedy I, Griffin SJ, Holman RR.

Fam Pract. 2009 Oct;26(5):351-8. Epub 2009 Jun 21.PMID: 19546119 [PubMed - in process]Related articles

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, Craven A, Goyder L, Holman RR, Mant D, Kinmonth AL, Neil HA; DiGEM Trial Group.

Health Technol Assess. 2009 Feb;13(15):iii-iv, ix-xi, 1-50.PMID: 19254484 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?

Price HC, Holman RR.

Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):168-9. Epub 2009 Jan 20.PMID: 19153560 [PubMed - indexed for MEDLINE]Related articles

Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes.

Hartweg J, Farmer AJ, Holman RR, Neil A.

Curr Opin Lipidol. 2009 Feb;20(1):30-8.PMID: 19133409 [PubMed - indexed for MEDLINE]Related articles

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.

Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ.

Diabetes Care. 2009 Apr;32(4):708-13. Epub 2008 Dec 29.PMID: 19114615 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.

Price HC, Coleman RL, Stevens RJ, Holman RR.

Diabetologia. 2009 Mar;52(3):394-7. Epub 2008 Dec 2.PMID: 19048226 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.

Holman RR, Paul S, Farmer A, Tucker L, Stratton IM, Neil HA; Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes Study Group.

Diabetologia. 2009 Jan;52(1):50-9. Epub 2008 Nov 11.PMID: 19002433 [PubMed - indexed for MEDLINE]Related articles

Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia.

Gloyn AL, van de Bunt M, Stratton IM, Lonie L, Tucker L, Ellard S, Holman RR.

Diabetologia. 2009 Jan;52(1):172-4. Epub 2008 Nov 11. No abstract available. PMID: 19002431 [PubMed - indexed for MEDLINE]Related articles

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.

Califf RM, Boolell M, Haffner SM, Bethel MA, McMurray J, Duggal A, Holman RR; NAVIGATOR Study Group.

Am Heart J. 2008 Oct;156(4):623-32.PMID: 18946890 [PubMed - indexed for MEDLINE]Related articles

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes.

Diabetes Care. 2009 Jan;32(1):193-203. Epub 2008 Oct 22.PMID: 18945920 [PubMed - in process]Related articlesFree article

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes.

Diabetologia. 2009 Jan;52(1):17-30. Epub 2008 Oct 22.PMID: 18941734 [PubMed - indexed for MEDLINE]Related articles

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR.

N Engl J Med. 2008 Oct 9;359(15):1565-76. Epub 2008 Sep 10.PMID: 18784091 [PubMed - indexed for MEDLINE]Related articlesFree article

10-year follow-up of intensive glucose control in type 2 diabetes.

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.

N Engl J Med. 2008 Oct 9;359(15):1577-89. Epub 2008 Sep 10.PMID: 18784090 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial.

Price HC, Tucker L, Griffin SJ, Holman RR.

Cardiovasc Diabetol. 2008 Jul 17;7:21.PMID: 18637168 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group.

Diabetes Care. 2008 May;31(5):845-51. Epub 2008 Jan 25.PMID: 18223031 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B.

Diabetes Care. 2008 Jan;31(1):173-5. No abstract available. PMID: 18165348 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B.

Diabetologia. 2008 Jan;51(1):8-11. No abstract available. PMID: 18026926 [PubMed - indexed for MEDLINE]Related articles

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.

Cull CA, Jensen CC, Retnakaran R, Holman RR.

Circulation. 2007 Nov 6;116(19):2119-26. Epub 2007 Oct 22.PMID: 17967769 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC; 4-T Study Group.

N Engl J Med. 2007 Oct 25;357(17):1716-30. Epub 2007 Sep 21.PMID: 17890232 [PubMed - indexed for MEDLINE]Related articlesFree article

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.

Desai M, Cull CA, Horton VA, Christie MR, Bonifacio E, Lampasona V, Bingley PJ, Levy JC, Mackay IR, Zimmet P, Holman RR, Clark A.

Diabetologia. 2007 Oct;50(10):2052-60. Epub 2007 Jul 27.PMID: 17657474 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.

Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA.

Diabetologia. 2007 Aug;50(8):1593-602. Epub 2007 May 31. Review.PMID: 17541540 [PubMed - indexed for MEDLINE]Related articles

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.

Coleman RL, Stevens RJ, Retnakaran R, Holman RR.

Diabetes Care. 2007 May;30(5):1292-3. Epub 2007 Feb 8. No abstract available. PMID: 17290036 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group.

N Engl J Med. 2006 Dec 7;355(23):2427-43. Epub 2006 Dec 4. Erratum in: N Engl J Med. 2007 Mar 29;356(13):1387-8. PMID: 17145742 [PubMed - indexed for MEDLINE]Related articlesFree article

An association analysis of the HLA gene region in latent autoimmune diabetes in adults.

Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Walker M, Gillespie KM, Bingley PJ, Hitman GA, Holman RR, McCarthy MI, Clark A.

Diabetologia. 2007 Jan;50(1):68-73. Epub 2006 Dec 2.PMID: 17143607 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes.

Hartweg J, Farmer AJ, Holman RR, Neil HA.

Diabetologia. 2007 Feb;50(2):250-8. Epub 2006 Nov 21.PMID: 17119918 [PubMed - indexed for MEDLINE]Related articles

Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.

Calle R, McCarthy MI, Banerjee P, Zeggini E, Cull CA, Thorne KI, Wiltshire S, Terra S, Meyer D, Richmond J, Mancuso J, Milos P, Fryburg D, Holman RR.

Diabetologia. 2006 Dec;49(12):2892-9. Epub 2006 Oct 3.PMID: 17096118 [PubMed - indexed for MEDLINE]Related articles

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.

Wright AD, Cull CA, Macleod KM, Holman RR; for the UKPDS Group.

J Diabetes Complications. 2006 Nov-Dec;20(6):395-401.PMID: 17070446 [PubMed - indexed for MEDLINE]Related articles

A clinical screening tool identifies autoimmune diabetes in adults: response to Fourlanos et al.

Davis TM, Cull CA, Holman RR.

Diabetes Care. 2006 Nov;29(11):2560; author reply 2560-1. No abstract available. PMID: 17065707 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR.

Lancet. 2006 Sep 23;368(9541):1096-105. Erratum in: Lancet. 2006 Nov 18;368(9549):1770. PMID: 16997664 [PubMed - indexed for MEDLINE]Related articles

Effect of ramipril on the incidence of diabetes.

DREAM Trial Investigators, Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR.

N Engl J Med. 2006 Oct 12;355(15):1551-62. Epub 2006 Sep 15.PMID: 16980380 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B.

Diabetes Care. 2006 Aug;29(8):1963-72. No abstract available. Erratum in: Diabetes Care. 2006 Nov;49(11):2816-8. PMID: 16873813 [PubMed - indexed for MEDLINE]Related articlesFree article

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

Diabetes. 2006 Aug;55(8):2357-64.PMID: 16873701 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.

Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, Krähenbühl S, Diem P.

Am Heart J. 2006 Jul;152(1):27-38. Review.PMID: 16824829 [PubMed - indexed for MEDLINE]Related articles

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B; Professional Practice Committee, American Diabetes Association; European Association for the Study of Diabetes.

Diabetologia. 2006 Aug;49(8):1711-21. No abstract available. PMID: 16802130 [PubMed - indexed for MEDLINE]Related articles

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.

Clarke PM, Simon J, Cull CA, Holman RR.

Diabetes Care. 2006 Jul;29(7):1506-11.PMID: 16801570 [PubMed - indexed for MEDLINE]Related articlesFree article

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR.

Diabetologia. 2006 Aug;49(8):1761-9. Epub 2006 May 31.PMID: 16736131 [PubMed - indexed for MEDLINE]Related articles

The variable number of tandem repeats upstream of the insulin gene is a susceptibility locus for latent autoimmune diabetes in adults.

Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Hitman GA, Walker M, Holman RR, McCarthy MI, Clark A.

Diabetes. 2006 Jun;55(6):1890-4.PMID: 16731859 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group.

Diabetes. 2006 Jun;55(6):1832-9.PMID: 16731850 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.

Holman RR.

Metabolism. 2006 May;55(5 Suppl 1):S2-5. Review.PMID: 16631806 [PubMed - indexed for MEDLINE]Related articles

PROactive study.

Holman RR, Retnakaran R, Farmer A, Stevens R.

Lancet. 2006 Jan 7;367(9504):25-6; author reply 26-7. No abstract available. PMID: 16399144 [PubMed - indexed for MEDLINE]Related articles

Reporting of diabetes on death certificates using data from the UK Prospective Diabetes Study.

Thomason MJ, Biddulph JP, Cull CA, Holman RR.

Diabet Med. 2005 Aug;22(8):1031-6.PMID: 16026369 [PubMed - indexed for MEDLINE]Related articles

Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes.

Holman RR, Coleman RL, Shine BS, Stevens RJ.

Diabetes Care. 2005 Jul;28(7):1796-7. No abstract available. PMID: 15983339 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

Cook MN, Girman CJ, Stein PP, Alexander CM, Holman RR.

Diabetes Care. 2005 May;28(5):995-1000.PMID: 15855556 [PubMed - indexed for MEDLINE]Related articlesFree article